Claims

Most identified assessment tools demonstrate construct or concurrent validity, but predictive validity is absent across tool categories

Claim · All claims
Evidence · 1 study · review r3 · q3
Currency · newest study 2024 · not yet checked against its sources · not reviewed by a person · recheck by 2027: tool and model accuracy changes quickly

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q3 i? Relationships to other variables were reported for 10 of 13 global tools, 9 of 13 procedure-specific tool studies, and 9 of 11 APMs, via construct or concurrent validity. → Tesfai FM 2024

Evidence

Tesfai FM 2024

Tesfai FM, Nagi J, Morrison I, Boal M, Olaitan A, Chandrasekaran D, Stoyanov D, Lanceley A, Francis N. (2024). Objective assessment tools in laparoscopic or robotic‐assisted gynecological surgery: A systematic review. Acta Obstet Gynecol Scand. https://doi.org/10.1111/aogs.14840

q3 · i? · review · r3

Systematic review synthesis of validity evidence by tool category. For APMs the review reports "Nine out of 11 (81.8%) APM showed construct or criterion validity"; it similarly reports 10/13 global tools and 9/13 procedure-specific tool studies showing construct or concurrent validity, while predictive validity was absent.

"Nine out of 11 (81.8%) APM showed construct or criterion validity."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.